Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0252 Transporter Info
Gene Name	SLC2A10
Transporter Name	Glucose transporter type 10
Gene ID	81031
UniProt ID	O95528

Post-Translational Modification of This DT
Overview of SLC2A10 Modification Sites with Functional and Structural Information
Sequence	M G H S P P V L P L C A S V S L L G G L T F G Y E L A V I S G A L L P L Q L D F G L S C L E Q E F L V G S L L L G A L L A S L V G G F L I D C Y G R K Q A I L G S N L V L L A G S L T L G L A G S L A W L V L G R A V V G F A I S L S S M A C C I Y V S E L V G P R Q R G V L V S L Y E A G I T V G I L L S Y A L N Y A L A G T P W G W R H M F G W A T A P A V L Q S L S L L F L P A G T D E T A T H K D L I P L Q G G E A P K L G P G R P R Y S F L D L F R A R D N M R G R T T V G L G L V L F Q Q L T G Q P N V L C Y A S T I F S S V G F H G G S S A V L A S V G L G A V K V A A T L T A M G L V D R A G R R A L L L A G C A L M A L S V S G I G L V S F A V P M D S G P S C L A V P N A T G Q T G L P G D S G L L Q D S S L P P I P R T N E D Q R E P I L S T A K K T K P H P R S G D P S A P P R L A L S S A L P G P P L P A R G H A L L R W T A L L C L M V F V S A F S F G F G P V T W L V L S E I Y P V E I R G R A F A F C N S F N W A A N L F I S L S F L D L I G T I G L S W T F L L Y G L T A V L G L G F I Y L F V P E T K G Q S L A E I D Q Q F Q K R R F T L S F G H R Q N S T G I P Y S R I E I S A A S
PTM type	X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	334
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC2A10 Asparagine 334 has the potential to affect its expression or activity.
Phosphorylation
Serine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Serine 217 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A10			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	369
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Serine 369 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC2A10			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	520
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Serine 520 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC2A10			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	527
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Serine 527 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC2A10			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	533
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Serine 533 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	370
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Threonine 370 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A10			[5] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	518
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Threonine 518 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC2A10			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	528
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Threonine 528 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	532
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A10 Tyrosine 532 has the potential to affect its expression or activity.
Ubiquitination
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[3] , [11]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	229
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC2A10 Arginine 229 has the potential to affect its expression or activity.
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[3] , [11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	208
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC2A10 Lysine 208 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A10			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	514
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC2A10 Lysine 514 has the potential to affect its expression or activity.
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A10			[3] , [11]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	211
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC2A10 Proline 211 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR10_HUMAN)
2	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
4	Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. J Proteome Res. 2006 May;5(5):1252-60.
5	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
6	A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res. 2012 Nov 2;11(11):5311-22.
7	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
8	Insights into chemoselectivity principles in metal oxide affinity chromatography using tailored nanocast metal oxide microspheres and mass spectrometry-based phosphoproteomics. Analyst. 2017 May 30;142(11):1993-2003.
9	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
10	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
11	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
12	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
13	Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. Proteomics. 2018 Aug;18(15):e1700388.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence